IRON (II) OXIDATION AND EARLY INTERMEDIATES OF IRON-CORE FORMATION IN RECOMBINANT HUMAN H-CHAIN FERRITIN

被引:85
作者
BAUMINGER, ER
HARRISON, PM
HECHEL, D
HODSON, NW
NOWIK, I
TREFFRY, A
YEWDALL, SJ
机构
[1] UNIV SHEFFIELD, KREBS INST BIOMOLEC RES, DEPT MOLEC BIOL & BIOTECHNOL, SHEFFIELD S10 2TN, S YORKSHIRE, ENGLAND
[2] HEBREW UNIV JERUSALEM, RACAH INST PHYS, JERUSALEM, ISRAEL
基金
英国惠康基金;
关键词
D O I
10.1042/bj2960709
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The paper describes a study of Fe(II) oxidation and the formation of Fe(III)-apoferritin complexes in recombinant human H-chain ferritin and its variants. The effects of site-directed changes in the conserved residues associated with a proposed ferroxidase centre have been investigated. A change in any of these residues is shown to reduce the rate of Fe(II) oxidation, confirming the importance of the ferroxidase centre in the catalysis of Fe(II) oxidation. Mossbauer and u.v.-difference spectroscopy show that in the wild-type protein Fe(II) oxidation gives rise to Fe(III) monomers, dimers and larger clusters. The formation of Fe(III) mu-oxo-bridged dimers occurs at the ferroxidase centre and is associated with fast oxidation: in three variants in which Fe(II) oxidation is especially slow, no Fe(III) dimers are seen. Within the time scale 0.5-20 min in wild-type human H-chain ferritin, dimer formation precedes that of the monomer and the progression dimer --> monomer --> cluster is observed, although not to completion. In a preliminary investigation of oxidation intermediates using a stopped-flow instrument, an Fe(III)-tyrosine complex reported by Waldo et al. (1993), is attributed to Tyr-34, a residue at the ferroxidase centre. The Fe(III)-Tyr-34 complex, forms in 0.5 s and then decays, as dimer absorbance increases. The relationship between Fe(III)-tyrosinate and the formation of Fe(III) dimers is uncertain.
引用
收藏
页码:709 / 719
页数:11
相关论文
共 35 条
[1]   STRUCTURE, FUNCTION, AND EVOLUTION OF FERRITINS [J].
ANDREWS, SC ;
AROSIO, P ;
BOTTKE, W ;
BRIAT, JF ;
VONDARL, M ;
HARRISON, PM ;
LAULHERE, JP ;
LEVI, S ;
LOBREAUX, S ;
YEWDALL, SJ .
JOURNAL OF INORGANIC BIOCHEMISTRY, 1992, 47 (3-4) :161-174
[2]  
ANDROSIO P, 1992, J BIOL CHEM, V293, P164
[3]  
AROSIO P, 1978, J BIOL CHEM, V253, P4451
[4]  
ARTYMIUK PJ, 1991, IRON BIOMINERALS, P269
[5]   MOSSBAUER SPECTROSCOPIC INVESTIGATION OF STRUCTURE-FUNCTION RELATIONS IN FERRITINS [J].
BAUMINGER, ER ;
HARRISON, PM ;
HECHEL, D ;
NOWIK, I ;
TREFFRY, A .
BIOCHIMICA ET BIOPHYSICA ACTA, 1991, 1118 (01) :48-58
[6]   MOSSBAUER SPECTROSCOPIC STUDY OF THE INITIAL-STAGES OF IRON-CORE FORMATION IN HORSE SPLEEN APOFERRITIN - EVIDENCE FOR BOTH ISOLATED FE(III) ATOMS AND OXO-BRIDGED FE(III) DIMERS AS EARLY INTERMEDIATES [J].
BAUMINGER, ER ;
HARRISON, PM ;
NOWIK, I ;
TREFFRY, A .
BIOCHEMISTRY, 1989, 28 (13) :5486-5493
[7]   CATALYTIC ACTIVITY OF HORSE SPLEEN APOFERRITIN - PRELIMINARY KINETIC STUDIES AND EFFECT OF CHEMICAL MODIFICATION [J].
BRYCE, CFA ;
CRICHTON, RR .
BIOCHEMICAL JOURNAL, 1973, 133 (02) :301-&
[8]   IRON DETOXIFYING ACTIVITY OF FERRITIN - EFFECTS OF HUMAN H-APOFERRITIN AND L-APOFERRITIN ON LIPID-PEROXIDATION INVITRO [J].
COZZI, A ;
SANTAMBROGIO, P ;
LEVI, S ;
AROSIO, P .
FEBS LETTERS, 1990, 277 (1-2) :119-122
[9]   IRON AND ALUMINUM IN RELATION TO BRAIN FERRITIN IN NORMAL INDIVIDUALS AND ALZHEIMERS-DISEASE AND CHRONIC RENAL-DIALYSIS PATIENTS [J].
DEDMAN, DJ ;
TREFFRY, A ;
CANDY, JM ;
TAYLOR, GAA ;
MORRIS, CM ;
BLOXHAM, CA ;
PERRY, RH ;
EDWARDSON, JA ;
HARRISON, PM .
BIOCHEMICAL JOURNAL, 1992, 287 :509-514
[10]   FERRITIN - DESIGN AND FORMATION OF AN IRON-STORAGE MOLECULE [J].
FORD, GC ;
HARRISON, PM ;
RICE, DW ;
SMITH, JMA ;
TREFFRY, A ;
WHITE, JL ;
YARIV, J .
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES, 1984, 304 (1121) :551-+